Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myelomaBortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma, Published online: 08 November 2018; doi:10.1038/s41408-018-0147-7Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

http://feeds.nature.com/~r/bcj/rss/current/~3/MfssQXsai-U/s41408-018-0147-7

Source: Blood Cancer Journal - November 8, 2018 Category: Hematology Authors: M. Hasib Sidiqi Mohammed A. Aljama Irbaz Bin Riaz Angela Dispenzieri Eli Muchtar Francis K. Buadi Rahma Warsame Martha Q. Lacy David Dingli Nelson Leung Wilson I. Gonsalves Prashant Kapoor Taxiarchis V. Kourelis William J. Hogan S. Vincent Rajkumar Shaji Source Type: research